Neratinib Temsirolimus in HER2-Mutant Lung Cancers: An International, Randomized Phase II Study

被引:41
作者
Gandhi, Leena [1 ]
Besse, Benjamin [2 ]
Mazieres, Julien [3 ]
Waciar, Saiama [4 ]
Cortot, Alexis [5 ]
Barlesi, Fabrice [6 ]
Quoix, Elisabeth [7 ]
Otterson, Gregory [8 ]
Ettinger, David [9 ]
Horn, Leora [10 ]
Moro-Sibilot, Denis [11 ]
Socinski, Mark [12 ]
Gold, Kathryn [13 ]
Gray, Jhanelle [14 ]
Oton, Ana [15 ]
Heist, Rebecca Suk [16 ]
Costa, Daniel [17 ]
Mcculloch, Leanne [18 ]
Bebchuk, Judith [18 ]
Bryce, Richard [18 ]
Kris, Mark [19 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Dept Canc Med, Villejuif, France
[3] CHU Toulouse, Hop Larrey, Toulouse, France
[4] Washington Univ, Sch Med, St Louis, MO USA
[5] Univ Lille, CHU Lille, Hop Calmette, Lille, France
[6] Aix Marseille Univ, Aphm, Marseille, France
[7] Hop Univ Strasbourg, Strasbourg, France
[8] Ohio State Univ, Columbus, OH 43210 USA
[9] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
[10] Vanderbilt Univ, Nashville, TN 37235 USA
[11] CHU Grenoble, Hop Albert Michallon, Grenoble, France
[12] Florida Hosp Canc Inst, Orlando, FL USA
[13] MD Anderson Canc Ctr, Houston, TX USA
[14] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[15] Univ Colorado, Aurora, CO USA
[16] Massachusetts Gen Hosp, Boston, MA 02114 USA
[17] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[18] Puma Biotechnol Inc, Los Angeles, CA USA
[19] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
NSCLC; Neratinib; Temsirolimus; lung cancer;
D O I
10.1016/j.jtho.2016.11.398
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MA04.02
引用
收藏
页码:S358 / S359
页数:2
相关论文
empty
未找到相关数据